107 related articles for article (PubMed ID: 11903687)
1. Growth fractions of human renal cell carcinoma defined by monoclonal antibody Ki-67. Predictive values for prognosis.
Yuba H; Okamura K; Ono Y; Ohshima S
Int J Urol; 2001 Nov; 8(11):609-14. PubMed ID: 11903687
[TBL] [Abstract][Full Text] [Related]
2. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.
Rioux-Leclercq N; Turlin B; Bansard J; Patard J; Manunta A; Moulinoux JP; Guillé F; Ramée MP; Lobel B
Urology; 2000 Apr; 55(4):501-5. PubMed ID: 10736491
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of growth fractions of renal cell carcinoma by the monoclonal antibody Ki-67].
Seki H; Demura T; Nagamori S; Nonomura K; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1994 Apr; 85(4):649-54. PubMed ID: 8189663
[TBL] [Abstract][Full Text] [Related]
4. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
5. Significance of conventional and new prognostic factors for locally confined renal cell carcinoma.
Hofmockel G; Tsatalpas P; Müller H; Dämmrich J; Poot M; Maurer-Schultze B; Müller-Hermelink HK; Frohmüller HG; Bassukas ID
Cancer; 1995 Jul; 76(2):296-306. PubMed ID: 8625106
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
8. MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis.
Mehdi MZ; Nagi AH; Naseem N
Int Braz J Urol; 2016; 42(6):1121-1128. PubMed ID: 27532114
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.
Visapää H; Bui M; Huang Y; Seligson D; Tsai H; Pantuck A; Figlin R; Rao JY; Belldegrun A; Horvath S; Palotie A
Urology; 2003 Apr; 61(4):845-50. PubMed ID: 12670587
[TBL] [Abstract][Full Text] [Related]
11. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM
Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinoma.
Rioux-Leclercq N; Delcros JG; Bansard JY; Epstein JI; Patard JJ; Lobel B; Guillé F; Jouan F; Bellaud P; Moulinoux JP
Hum Pathol; 2004 Oct; 35(10):1279-84. PubMed ID: 15492997
[TBL] [Abstract][Full Text] [Related]
13. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter.
Kamai T; Takagi K; Asami H; Ito Y; Arai K; Yoshida KI
BJU Int; 2000 Jul; 86(1):14-9. PubMed ID: 10886076
[TBL] [Abstract][Full Text] [Related]
15. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
Cheville JC; Terrell RB; Cohen MB
Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
[TBL] [Abstract][Full Text] [Related]
16. Primary apoptosis as a prognostic index for the classification of metastatic renal cell carcinoma.
Richter EN; Oevermann K; Buentig N; Storkel S; Dallmann I; Atzpodien J
J Urol; 2002 Aug; 168(2):460-4. PubMed ID: 12131288
[TBL] [Abstract][Full Text] [Related]
17. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma.
Chen K; Lee BL; Huang HH; Tan BY; Lee LS; Ng LG; Lau W; Yuen JS
Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999
[TBL] [Abstract][Full Text] [Related]
18. Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer.
Rudolph P; Alm P; Heidebrecht HJ; Bolte H; Ratjen V; Baldetorp B; Fernö M; Olsson H; Parwaresch R
J Natl Cancer Inst; 1999 Feb; 91(3):271-8. PubMed ID: 10037106
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of Ki-67 expression in renal cell carcinomas.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K
Eur Urol; 1997; 31(3):350-5. PubMed ID: 9129930
[TBL] [Abstract][Full Text] [Related]
20. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters.
Delahunt B; Kittelson JM; McCredie MR; Reeve AE; Stewart JH; Bilous AM
Cancer; 2002 Feb; 94(3):658-64. PubMed ID: 11857297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]